Blazejewski MEDI-TECH GmbH
Desconocido
MIB: Multi modal Endoscopic Biophotonic Imaging of Bladder Cancer for Point of Care Diagnosis
Blazejewski MEDITECH GMBH
participó en un
H2020:
H2020-PHC-2014-2015
Bladder cancer is among the most expensive diseases in oncology in terms of treatment costs; each procedure requires days of hospitalisation...
2015-12-09 - 2021-12-31 | Financiado
2015-12-09 - 2021-12-31 | Financiado
* No se disponen de datos de la empresa actual.